Abstract:Background: Managing healing of impaired bone fracture has long been a subject of concern. Prolonged or uncontrolled inflammation exerts detrimental effects on bone healing. Tμmor necrosis factor (TNF)-α is a critical inflammatory factor, whose absence impairs normal bone formation. However, TNF-α exposure for longer duration inhibits bone regeneration. In this study, we aim to find a new therapeutic target for the impaired osteogenesis induced by long exposure of TNF-α.Methods: In vitro, mRNA microarray analysis was used to identify differentially expressed genes. Cell proliferation assay was used to assess the proliferation of cells. qPCR and Western blotting analysis were applied to detect the expression of target genes and proteins respectively. ALP staining and Alizarin Red staining (ARS) were used to evaluate ALP activity and mineral deposition respectively. Co-immunoprecipitation was used to detect the interaction of proteins. In vitro , a murine tibial fracture model was established, histological evaluation and radiographic analysis was used to confirm bone regeneration in fracture healing. statistical significance between two groups was determined by Student’s t test, one-way ANOVA or Bonferroni’s post-hoc test according to the distribution of the tested population.Results: In this study, we show that heat shock protein family B (small) member 7 (HSPB7) mitigates negative impact of long-term TNF-α exposure on bone formation by binding heat shock protein family H (small) member 1 (HSPH1). HSPH1, in turn, inhibits the ATPase of heat shock cognate A8 (HSCA8), one of the key components involved in chaperone-mediated autophagy (CMA). Deletion of genes encoding for either HSCA8 or lysosome-associated membrane protein 2A (LAMP2A), another component of CMA, failed to reverse the osteogenic differentiation of hBMSCs induced by TNF-α by deleting HSPH1.Subsequently, transcriptome analysis was further used to explore downstream related pathways mediated by CMA. After LAMP2a gene knockdown, transcriptional analysis showed that the PI3K/AKT/GSK3β signaling pathway was significantly inhibited. LAMP2A overexpression reverse the impaired osteogenesis induced by TNF-α, and this effect was attenuated by DKK1, a specific Wnt/β-catenin signaling pathway inhibitors. Finally, we successfully constructed a mouse tibial fracture model and locally injected TNF-α to simulate the chronic inflammatory environment. Histological and imaging results showed that TNF-α significantly inhibited fracture healing, while the addition of HSPB7 overexpressed lentivirus successfully saved fracture healing. Thus, a heat shock protein family network composed by HAPB7, HSPH1 and HSCA8 rescued the impairment of bone healing by TNF-α through the CMA-mediated PI3K/AKT/GSK3β signaling pathway., making it a potential therapeutic agent for bone regeneration in cases of prolonged or severe inflammation in the clinical settings.Conclusions: Taken together, these findings indicate that a heat shock protein family network including HSPB7, HSPH1 and HSCA8 protects the impaired osteogenesis induced by TNF-α via CMA through PI3K/AKT/GSK3β/β-catenin pathway. And in vivo, HSPB7 overexpression lentiviral particles effectively protects the impaired fracture healing induced by TNF-α in a mouse tibia fracture healing model.Funding: This work was supported by grants from the National Natural Science Foundation of China (Nos. 81672147; Nos. 81874007).Declaration of Interest: The authors declare no conflicts of interest.Ethical Approval: All animal experiments were in accordance to the Animal Care and Use Committee guidelines of Zhejiang University. All experimental procedures were in accordance with the and Institutional Animal Care Use Committee at Zhejiang University.

MAGP2 promotes osteogenic differentiation during fracture healing through its crosstalk with the β‐catenin pathway

Chaperone‐mediated autophagy protects the bone formation from excessive inflammation through <scp>PI3K/AKT/GSK3β</scp>/β‐catenin pathway

Microfibril-Associated Glycoprotein-1, an Extracellular Matrix Regulator of Bone Remodeling

The Effect of MMP-2 Inhibitor 1 on Osteogenesis and Angiogenesis During Bone Regeneration.

Magnesium malate-modified calcium phosphate bone cement promotes the repair of vertebral bone defects in minipigs via regulating CGRP

HSPB7 Protects Bone Formation from TNF-α Via Chaperone Mediated Autophagy Through PI3K/AKT/GSK3β/Β-Catenin Pathway

Macrophage MSR1 Promotes BMSC Osteogenic Differentiation and M2-like Polarization by Activating PI3K/AKT/GSK3β/β-catenin Pathway

Accelerated fracture healing in transgenic mice overexpressing an anabolic isoform of fibroblast growth factor 2

MFG-E8 Promotes Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Through GSK3/-catenin Signaling Pathway

Oophorectomy‐induced Bone Loss is Attenuated in MAGP1‐deficient Mice

BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression Is Essential During Fracture Repair

MFG-E8 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells through GSK3β/β-catenin signaling pathway

Endogenous Parathyroid Hormone Promotes Fracture Healing by Increasing Expression of BMPR2 through cAMP/PKA/CREB Pathway in Mice

Chaperone‐mediated autophagy protects the bone formation from excessive inflammation through PI3K/AKT/GSK3β/β‐catenin pathway

β-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model

Magnetically-Targeted Nanoparticle-Guided M2 Macrophage Polarization For Fracture Healing Promotion

Mangiferin Enhances Endochondral Ossification‐based Bone Repair in Massive Bone Defect by Inducing Autophagy Through Activating AMP‐activated Protein Kinase Signaling Pathway

Knockdown of Ggps1 in chondrocyte expedites fracture healing by accelerating the progression of endochondral ossification in mice

MiR-140-5p Promotes Osteogenic Differentiation of Mouse Embryonic Bone Marrow Mesenchymal Stem Cells and Post-Fracture Healing of Mice

Nerve growth factor promotes osteogenic differentiation of MC3T3-E1 cells via BMP-2/Smads pathway